Skip to content
Life Sciences Series C Founded 2010

Biobot Surgical

Developer of surgical automation devices. The products include robotic transperineal biopsy device (rTPB), developed through collaborative partnership that enables surgeons to extract prostate biopsy tissues through 2 small needle puncture incisions on the perineal skin. Founded in 2010, headquartered in Singapore, Singapore. The company has raised $25.7M in funding at the series c stage. The team comprises 47 (Jun…

📍 Singapore, Singapore · Surgical Instruments,

Funding snapshot

Last roundSeries C
Amount$8M
Date9 April 2026
Total raised$26M
Valuation53,000,000 (Apr 15, 2025)
Team size47

About

Developer of surgical automation devices. The products include robotic transperineal biopsy device (rTPB), developed through collaborative partnership that enables surgeons to extract prostate biopsy tissues through 2 small needle puncture incisions on the perineal skin. Founded in 2010, headquartered in Singapore, Singapore. The company has raised $25.7M in funding at the series c stage. The team comprises 47 (Jun 30, 2026) employees. Backed by investors including ZIG Ventures, Clavystbio. Biobot Surgical operates in the Surgical Instruments, Professional Service Robots sectors. The company focuses on Surgery, Robotic Surgery. The company has a team of 47 employees. The company is categorized under Life Sciences > Surgical Instruments; High Tech > Professional Service Robots.

Business model

Professional Service Robots > Healthcare > Surgery,

Surgical Instruments > Robotic Surgery

Institutional investors

ZIG Ventures Clavystbio Tony Tan Wai Hoong Tang Yew Bock Tan Aw May Ling Lennard Harold Thean See Yin Joseph Lee

Latest coverage

No articles yet.

Raising like Biobot Surgical?

Analyze your pitch deck before your next raise.

Analyze My Deck →